Interestingly, only 1/6 long-term tumor-free mice, depleted for CD4+ T cells one day before vaccination, in the TC-1 model developed tumor when challenged with the secondary dose of TC-1 cells 60 days post-primary tumor challenge. Here, CD4 is linked to neoplasm.